Metraipolis › archive › dc_2b54964ade95

A Perspective on a Possible New Role for Bevacizumab Combined with Paclitaxel in Hormone-Resistant Metastatic Breast-Cancer Patients — Europe PMC PMID:42652576

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42652576
DOI
10.3390/jcm15166172
License (as archived)
solo-consultazione
Archived
2026-10-16T22:30:38.811Z
SHA-256 of the archived text
11cdc2c67486f13edc19188f75e3ec31a2fadb188dc15d6f2b8f70bdc2d96841
Stable URL of this page
https://metraipolis.com/documento/dc_2b54964ade95

How to cite

A Perspective on a Possible New Role for Bevacizumab Combined with Paclitaxel in Hormone-Resistant Metastatic Breast-Cancer Patients — Europe PMC PMID:42652576 — Europe PMC (en), https://europepmc.org/article/MED/42652576 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2b54964ade95 (Metraipolis archive dc_2b54964ade95, sha256 11cdc2c67486f13edc19188f75e3ec31a2fadb188dc15d6f2b8f70bdc2d96841)
BibTeX
@misc{dc2b54964ade95,
  title = {A Perspective on a Possible New Role for Bevacizumab Combined with Paclitaxel in Hormone-Resistant Metastatic Breast-Cancer Patients — Europe PMC PMID:42652576},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42652576},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2b54964ade95; sha256 11cdc2c67486f13edc19188f75e3ec31a2fadb188dc15d6f2b8f70bdc2d96841},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42652576. Agents can read the archived copy with the MCP tool read_document.